Outset Medical (OM) reported Q2 2026 revenue of $31.6M, up 1% YoY and 14% sequentially, citing improving commercial traction and margins. The company also signed a new $40M refresh agreement with HCA Healthcare, supporting near-term revenue visibility. Overall, the combination of sequential growth and the larger customer agreement is a modest positive for the stock.
Outset Medical (OM) reported Q2 2026 revenue of $31.6M, up 1% YoY and 14% sequentially, citing improving commercial traction and margins. The company also signed a new $40M refresh agreement with HCA Healthcare, supporting near-term revenue visibility. Overall, the combination of sequential growth and the larger customer agreement is a modest positive for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
